Biochemical Profiling in Human Populations by Dr. Gerszten (BIDMC)

Robert Gerszten, MD, reviews how emerging technologies allow investigators to assay thousands of metabolites and proteins in the blood and tissues. Dr. Gerszten discusses clinical questions particularly amenable to these technologies, as well as potential barriers to implementation. He also reviews how integrating metabolomics and proteomics with human genetics can be used to identify novel disease pathway.